611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
AHA News: Health Emergency? Don't Hesitate to Get HelpToo Many Patients, Too Few Ventilators: How U.S. Hospitals Cope With COVID-19AI Might Spot Which COVID-19 Patients Are at Risk of Severe DiseaseWhat Dental Offices Are Doing to Prevent Coronavirus Infection?A Parent's Guide to Fighting Coronavirus StressTrump Extends Social Distancing to April 30 as COVID-19 Cases SurgeRecovery From Mild Brain Trauma Takes Longer Than Expected: StudyStaying at Home During the Pandemic? Use Technology to Stay ConnectedAHA News: Understanding the Basics of 'Herd Immunity'Multiple Measures of Social Distancing Required to Slow Coronavirus: StudyCough, Fever, Fatigue? Head to CDC's Online Coronavirus Symptom CheckerThree Countries Have Kept Coronavirus in Check; Here's How They Did ItTrial Finds Acupuncture May Help Prevent MigrainesSevere COVID-19 Might Injure the HeartWhy Are Teens, Millennials Ignoring Coronavirus Warnings?An Expert's Guide to Fact-Checking Coronavirus Info OnlineLivestock, Poultry Safe From Coronavirus: ExpertWuhan Study Shows How Social Distancing Is Saving LivesU.S. Hospital Beds Were Already Maxed Out Before Coronavirus PandemicFDA Warns of Defective EpiPen DangersPoll Finds High Anxiety in the Time of CoronavirusCould Robots Be Deployed to Front Line in Fighting COVID-19?COVID-19 May Force Some Cancer Patients to Delay TreatmentWhat People With Parkinson's Need to Know About COVID-19How to Weather Social Isolation During Coronavirus PandemicCOVID-19 Infection Likely Worse for Vapers, SmokersWhen Arteries Narrow, Chest Pain Can Come Earlier for Women Than MenLoss of Sense of Smell Could Be Early Sign of Coronavirus InfectionMany Drugs Already Approved by FDA May Have Promise Against COVID-19The Other Side of COVID-19: Milder Cases, Healthy RecoveryAs Coronavirus Myths Multiply, Experts Sort Fact From FictionA Third of Americans Ordered to Stay at Home; Summer Olympics Postponed for One YearWeight-Loss Surgery May Cut Risk of Heart Attack, StrokeFDA Warns Americans to Beware of Fake COVID-19 Test KitsTaking Steroids for Rheumatoid Arthritis, IBD? Your Odds for Hypertension May RiseWhat Does a Self-Quarantine Look Like?National Guard Activated in 3 States as U.S. Coronavirus Cases Top 34,000U.S. Coronavirus Cases Pass 26,000, With 1 in 4 Americans Under 'Shelter-in-Place' OrdersRaking Your Leaves to the Edge of Your Yard an Invitation to TicksNew Drug Helps Shrink Inoperable Tumors in KidsCoronavirus Crisis Should Put Elective Surgeries on Hold, Doctors' Group SaysAlmost Half of Coronavirus Patients Have Digestive SymptomsNearly 40% of Hospitalizations in U.S. COVID-19 Cases Involve Adults Under 55Healthy Living at Home to Ward Off CoronavirusWhat You Need to Know About Coronavirus If You Have AsthmaStudy Suggests COVID-19 Might Follow Seasonal PatternTrump Signs Massive Relief Package Into Law as U.S. Coronavirus Cases Reach 10,000AHA News: A Look at Allergies and Heart Health, With Tips to Endure Pollen Season Amid Coronavirus FearsNew Coronavirus Wasn't Made in a Lab, Genomic Study ShowsWho's Most at Risk From Coronavirus?
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Lab Discovery Offers Promise for Treating Multiple Sclerosis

HealthDay News
by -- Robert Preidt
Updated: Feb 5th 2020

new article illustration

WEDNESDAY, Feb. 5, 2020 (HealthDay News) -- A new discovery could lead to better treatments for multiple sclerosis (MS) and other autoimmune diseases, such as psoriasis and rheumatoid arthritis, researchers report.

MS occurs when immune cells get into the central nervous system (the brain and spinal cord), causing nerve damage that results in neurological problems. However, the cause is unclear.

Studies in a mouse model of MS -- called experimental autoimmune encephalomyelitis (EAE) -- have shown that immune T-cells, which secrete an immune molecule called IL-17, damage the myelin sheath surrounding nerves in the central nervous system (CNS).

Drugs that block IL-17 have shown promise in early clinical trials for treatment of relapsing-remitting MS. The drugs have already been licensed for treating psoriasis.

In this new study, researchers at Trinity College Dublin, in Ireland, identified another role that IL-17 plays in EAE, and possibly in MS. However, research in animals doesn't always pan out in humans.

"A key role of IL-17 is to mobilize and activate an army of disease-causing immune cells in the lymph nodes that then migrate to the CNS to cause the nerve damage," study co-leader Kingston Mills said in a college news release. He's a professor of experimental immunology.

Study co-leader Aoife McGinley said the findings suggest that drugs that block IL-17 may not need to cross the blood-brain barrier to effectively treat MS. She's a postdoctoral fellow in the School of Biochemistry and Immunology.

"So, as well as shedding new light on the importance of IL-17 as a drugs target in [relapsing-remitting] MS, our research highlights the huge potential of drugs that block IL-17 in the treatment of other autoimmune diseases, such as psoriasis and rheumatoid arthritis," she said in the news release.

The study was published Feb. 4 in the journal Immunity.

MS affects about 2.3 million people worldwide.

More information

The American Academy of Family Physicians has more on multiple sclerosis.